TABLE 1.
Type of infection in dually HIV-1- and HIV-2-seroreactive individuals determined with ELISA-HIV2 and PCR amplification
| Sample | Result by ELISA-HIV2 (S/CO)
|
HIV-1 viral loada | Result by PCR amplificationb
|
Type of infection | |||
|---|---|---|---|---|---|---|---|
| rgp36 | rpC2-C3 | HIV-1
|
HIV-2 (env) | ||||
| gag | env | ||||||
| 107 | 9.35 | 11.87 | <50 | − | − | + | HIV-2 |
| 108 | 8.53 | 1.89 | <50 | − | − | + | HIV-2 |
| 109 | 8.68 | 4.11 | <50 | − | − | + | HIV-2 |
| 110 | 2.58 | 0.55 | 241 | − | + | − | HIV-1 |
| 111 | 8.25 | 3.32 | <50 | − | − | + | HIV-2 |
| 112 | 0.51 | 0.49 | 47,273 | + | + | − | HIV-1 |
| 113 | 0.80 | 0.50 | 35,123 | + | + | − | HIV-1 |
a
Number of RNA copies/ml of plasma.
b
Amplification of p17 (gag) and C2-C3 (env) regions. −, negative; +, positive.